Clinical trial

Comparator-Controlled Study for EGFR(+) Patients With Multiple BMs From NSCLC (BROKE) (EGFR-epidermal Growth Factor Receptor;BM-brain Metastases)

NCT02338011

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2014-11-01

PhasePHASE2 / PHASE3

Study timeline

Study start (unknown)2014-11-01Date precision: month

Registry last updated2015-01-26

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small Cell Lung Cancerunresolved

Brain Metastasesunresolved

EGFR Gene Mutationunresolved

Interventions

GefitinibDRUG · verified · RxNorm: gefitinib

WBRTRADIATION

Sponsors & collaborators

Shanghai Chest Hospitallead sponsor

Mapped research locations

ShanghaiShanghai Municipality, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02338011 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.